GW Pharmaceuticals (GWP)

 

Latest News

Broker Forecast - Numis issues a broker note on GW Pharmaceuticals PLC

Numis today reaffirms its hold investment rating on GW Pharmaceuticals PLC (LON:GWP) and set its price target at 835p...

Second Positive Phase 3 Trial for Epidiolex in LGS

RNS Number: 8260K GW Pharmaceuticals PLC 26 September 2016 GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome - Primary endpoint achieved in both Epidiolex doses with high statistical significance compared to placebo - - Today's data represents the third positive Pha...

Director Deals - GW Pharmaceuticals PLC (GWP)

Dr Stephen Wright, Executive Director, exercised 198,288 shares in the company on the 13th September 2016 at a price of 28...

Director/PDMR Shareholding

RNS Number: 8758J GW Pharmaceuticals PLC 14 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 1. Details of the person discharging managerial responsibilities / person closely associated a. Name Dr Stephen Wright 2. Reason for the notification a. Position/sta...

All News

DateHeadlineSource
27-09-16Broker Forecast - Numis issues a broker note on GW Pharmaceuticals PLCStockMarketWire
26-09-16Second Positive Phase 3 Trial for Epidiolex in LGSRNS
14-09-16Director Deals - GW Pharmaceuticals PLC (GWP)StockMarketWire
14-09-16Director/PDMR ShareholdingRNS
07-09-16Presenting at Morgan Stanley Healthcare ConferenceRNS
31-08-16Total Issued Share CapitalRNS
26-08-16Broker Forecast - Numis issues a broker note on GW Pharmaceuticals PLCStockMarketWire
17-08-16Block listing Interim ReviewRNS
09-08-16Are GlaxoSmithKline plc and GW Pharmaceuticals plc simply too expensive?Motley Fool
09-08-163rd Quarter ResultsRNS
09-08-16Notification of Future Change to BoardRNS
02-08-16Notice of ResultsRNS
29-07-16Total Voting RightsRNS
25-07-16Holding(s) in CompanyRNS
21-07-16Holding(s) in CompanyRNS
21-07-16Holding(s) in CompanyRNS
19-07-16Total Voting RightsRNS
18-07-16Closing of U.S. Public Offering Raising $289.8mRNS
13-07-16GW prices ADS offering to raise $252mStockMarketWire
13-07-16US Public Offering of ADSs Raising $252.0 MillionRNS
13-07-16Proposed Public Offering of ADSsRNS
01-07-16Three AIM stars of the futureInteractive Investor
01-07-16Holding(s) in CompanyRNS
01-07-16Holding(s) in CompanyRNS
30-06-16Total Voting RightsRNS
28-06-16Holding(s) in CompanyRNS
27-06-16Second Price Monitoring ExtnRNS
27-06-16Price Monitoring ExtensionRNS
27-06-16Positive Phase 3 Pivotal Trial ResultsRNS
27-06-16Holding(s) in CompanyRNS
23-06-16Holding(s) in CompanyRNS
22-06-16Holding(s) in CompanyRNS
21-06-16Epidiolex Development Program in Infantile SpasmsRNS
17-06-16Holding(s) in CompanyRNS
08-06-16Holding(s) in CompanyRNS
31-05-16Total Voting RightsRNS
31-05-16Presents at Goldman Sachs and Jefferies ConferenceRNS
16-05-16GWP presenting at UBS Global Healthcare ConferenceRNS
13-05-16Director Deals - GW Pharmaceuticals PLC (GWP)StockMarketWire
13-05-16Director/PDMR ShareholdingRNS

RSS feeds

  • Editorial news feed for LSE:GWP Editorial
  • Regulatory news feed for LSE:GWP Regulatory